Trial Information
Proprietary Information - Exploratory (Non-Confirmatory) Trial
Inclusion Criteria:
- Female, between the ages of 16 and 26
Exclusion Criteria:
- History of an abnormal PAP test or abnormal cervical biopsy result
- History of external genital/vaginal warts
- History of positive HPV test
- Currently a user of any illegal drugs or an alcohol abuser
- Are pregnant
- Currently enrolled in another clinical trial
- Currently has or has a history of certain medical conditions or is currently taking
or has taken certain medications (details will be discussed at the time of consent).
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Prevention
Outcome Measure:
Proprietary Information - Exploratory (Non-Confirmatory) Trial
Principal Investigator
Medical Monitor
Investigator Role:
Study Director
Investigator Affiliation:
Merck
Authority:
United States: Food and Drug Administration
Study ID:
2006_503
NCT ID:
NCT00365443
Start Date:
October 2006
Completion Date:
Related Keywords:
- Cervical Cancer
- Condylomata Acuminata
- anogenital warts
- premalignancy
- HPV
- Human papillomavirus
- Uterine Cervical Neoplasms
- Condylomata Acuminata